A carregar...
Protein Kinase CK2: A Targetable BCR-ABL Partner in Philadelphia Positive Leukemias
BCR-ABL-mediated leukemias, either Chronic Myeloid Leukemia (CML) or Philadelphia positive Acute Lymphoblastic Leukemia (ALL), are the paradigm of targeted molecular therapy of cancer due to the impressive clinical responses obtained with BCR-ABL specific tyrosine kinase inhibitors (TKIs). However,...
Na minha lista:
| Publicado no: | Adv Hematol |
|---|---|
| Main Authors: | , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Hindawi Publishing Corporation
2015
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4710905/ https://ncbi.nlm.nih.gov/pubmed/26843864 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2015/612567 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|